Advertisement
Australia markets open in 7 hours 31 minutes
  • ALL ORDS

    7,992.30
    -21.50 (-0.27%)
     
  • AUD/USD

    0.6659
    -0.0010 (-0.15%)
     
  • ASX 200

    7,750.70
    -16.80 (-0.22%)
     
  • OIL

    82.92
    +1.38 (+1.69%)
     
  • GOLD

    2,340.40
    +0.80 (+0.03%)
     
  • Bitcoin AUD

    94,727.16
    +2,329.23 (+2.52%)
     
  • CMC Crypto 200

    1,307.96
    +5.88 (+0.45%)
     

Oscar Health, Inc.'s (NYSE:OSCR) institutional investors lost 3.9% last week but have benefitted from longer-term gains

Key Insights

  • Institutions' substantial holdings in Oscar Health implies that they have significant influence over the company's share price

  • The top 11 shareholders own 51% of the company

  • Using data from analyst forecasts alongside ownership research, one can better assess the future performance of a company

Every investor in Oscar Health, Inc. (NYSE:OSCR) should be aware of the most powerful shareholder groups. We can see that institutions own the lion's share in the company with 60% ownership. Put another way, the group faces the maximum upside potential (or downside risk).

Losing money on investments is something no shareholder enjoys, least of all institutional investors who saw their holdings value drop by 3.9% last week. Still, the 116% one-year gains may have helped mitigate their overall losses. They should, however, be mindful of further losses in the future.

ADVERTISEMENT

Let's take a closer look to see what the different types of shareholders can tell us about Oscar Health.

Check out our latest analysis for Oscar Health

ownership-breakdown
ownership-breakdown

What Does The Institutional Ownership Tell Us About Oscar Health?

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

Oscar Health already has institutions on the share registry. Indeed, they own a respectable stake in the company. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see Oscar Health's historic earnings and revenue below, but keep in mind there's always more to the story.

earnings-and-revenue-growth
earnings-and-revenue-growth

Since institutional investors own more than half the issued stock, the board will likely have to pay attention to their preferences. Hedge funds don't have many shares in Oscar Health. Thrive Capital Management, LLC is currently the company's largest shareholder with 16% of shares outstanding. The Vanguard Group, Inc. is the second largest shareholder owning 6.2% of common stock, and Dragoneer Investment Group, LLC holds about 5.4% of the company stock.

Looking at the shareholder registry, we can see that 51% of the ownership is controlled by the top 11 shareholders, meaning that no single shareholder has a majority interest in the ownership.

Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. There are plenty of analysts covering the stock, so it might be worth seeing what they are forecasting, too.

Insider Ownership Of Oscar Health

The definition of an insider can differ slightly between different countries, but members of the board of directors always count. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.

I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.

We can report that insiders do own shares in Oscar Health, Inc.. The insiders have a meaningful stake worth US$110m. Most would see this as a real positive. It is good to see this level of investment by insiders. You can check here to see if those insiders have been buying recently.

General Public Ownership

The general public-- including retail investors -- own 17% stake in the company, and hence can't easily be ignored. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.

Private Equity Ownership

Private equity firms hold a 21% stake in Oscar Health. This suggests they can be influential in key policy decisions. Some investors might be encouraged by this, since private equity are sometimes able to encourage strategies that help the market see the value in the company. Alternatively, those holders might be exiting the investment after taking it public.

Next Steps:

I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. For example, we've discovered 1 warning sign for Oscar Health that you should be aware of before investing here.

If you would prefer discover what analysts are predicting in terms of future growth, do not miss this free report on analyst forecasts.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com